Skip to main content
Contact Us
Subscribe
E-Edition
46°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virpax Pharmaceuticals Inc
(NQ:
VRPX
)
0.6900
+0.1003 (+17.01%)
Streaming Delayed Price
Updated: 11:31 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 15, 2023
It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 14, 2023
Via
Benzinga
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
December 05, 2023
Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results for its third quarter and issued a stro
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
November 17, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Virpax Pharmaceuticals Announces Leadership Transition
November 17, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
November 15, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review
October 31, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
Via
Benzinga
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
October 12, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Gerald W. Bruce Appointed President and CEO of Novvae™ Pharmaceuticals
October 02, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies
September 27, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI
September 26, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
September 21, 2023
From
Altasciences
Via
Business Wire
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
September 18, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
September 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 05, 2023
Via
Benzinga
Virpax Pharmaceuticals Updates on Litigation
September 05, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 31, 2023
Via
Benzinga
Virpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference
August 28, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
August 14, 2023
From
Virpax® Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method
August 10, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 24, 2023
Via
Benzinga
Virpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023
July 24, 2023
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
July 21, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.